Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy

被引:7
作者
Juan, Yun-Ting [1 ]
Chiang, Wen-Chih [2 ]
Lin, Wei-Chou [3 ]
Yang, Cheng-Wen [1 ]
Chou, San-Fang [4 ]
Hung, Ruo-Wei [1 ]
Chiu, Yen-Ling [1 ,4 ,5 ,6 ,7 ]
机构
[1] Far Eastern Mem Hosp, Dept Nephrol, New Taipei 220, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med, Div Nephrol, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
[4] Far Eastern Mem Hosp, Dept Med Res, New Taipei 220, Taiwan
[5] Yuan Ze Univ, Grad Inst Med, Taoyuan 320, Taiwan
[6] Yuan Ze Univ, Grad Program Biomed Informat, Taoyuan 320, Taiwan
[7] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 100, Taiwan
关键词
complement C5a; factor Ba; galactose-deficient IgA1; IgA nephropathy; Oxford classification;
D O I
10.3390/jcm11144231
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our prior study indicates a close relationship between alternative complement pathway activation, galactose-deficient IgA1 (Gd-IgA1) concentration and clinical severity of IgA nephropathy (IgAN). Nonetheless, the relationship between complement factors and the updated Oxford classification of IgAN remains unclear. This study enrolled eighty-four previously untreated, biopsy-diagnosed IgAN patients. The clinical and laboratory findings were collected at the time of biopsy. Plasma levels of complement factor C5a, factor Ba and Gd-IgA1 were measured and analyzed. It was found that the levels of proteinuria positively correlated with the updated Oxford classification of mesangial hypercellularity (M), endocapillary hypercellularity (E), tubular atrophy/interstitial fibrosis (T) and crescents (C). In addition, plasma Gd-IgA1 titer was significantly elevated in IgAN patients with tubular atrophy/interstitial fibrosis (T). In separate multivariable logistic regression models, both Gd-IgA1 and factor Ba independently predict higher T scores. The results indicate that both the levels of Gd-IgA1 antibody and biomarkers of the alternative complement pathway activation reflect the Oxford classification of IgAN. Whether these biomarkers can be used to guide therapeutic decisions requires further study.
引用
收藏
页数:11
相关论文
共 50 条
[41]   N-Acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy [J].
Horynova, Milada Stuchlova ;
Vrablikova, Alena ;
Stewart, Tyler J. ;
Takahashi, Kazuo ;
Czernekova, Lydie ;
Yamada, Koshi ;
Suzuki, Hitoshi ;
Julian, Bruce A. ;
Renfrow, Matthew B. ;
Novak, Jan ;
Raska, Milan .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (02) :234-238
[42]   Galactose-deficient IgA1 Is Involved in IgA Deposition in Renal Grafts Biopsied One Hour after Kidney Transplantation [J].
Kuroyanagi, Yuki ;
Takeda, Asami ;
Kinashi, Hiroshi ;
Kuroyanagi, Yoshiyuki ;
Murata, Minako ;
Futamura, Kenta ;
Goto, Norihiko ;
Watarai, Yoshihiko ;
Ishimoto, Takuji ;
Morozumi, Kunio ;
Ito, Yasuhiko .
INTERNAL MEDICINE, 2023, 62 (11) :1581-1589
[43]   Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy [J].
Stefan, Gabriel ;
Alamartine, Eric ;
Mariat, Christophe ;
Maillard, Nicolas .
KIDNEY INTERNATIONAL REPORTS, 2024, 9 (02) :356-369
[44]   Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis A case report [J].
Han, Wei ;
Suzuki, Tomo ;
Watanabe, Shiika ;
Nakata, Mayumi ;
Ichikawa, Daisuke ;
Koike, Junki ;
Oda, Takashi ;
Suzuki, Hitoshi ;
Suzuki, Yusuke ;
Shibagaki, Yugo .
MEDICINE, 2021, 100 (05) :E24460
[45]   Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy [J].
Suzuki, Yusuke ;
Matsuzaki, Keiichi ;
Suzuki, Hitoshi ;
Okazaki, Keiko ;
Yanagawa, Hiroyuki ;
Ieiri, Norio ;
Sato, Mitsuhiro ;
Sato, Toshinobu ;
Taguma, Yoshio ;
Matsuoka, Joe ;
Horikoshi, Satoshi ;
Novak, Jan ;
Hotta, Osamu ;
Tomino, Yasuhiko .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (05) :770-777
[46]   Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model [J].
Li, Run ;
Wang, Manliu ;
Li, Jingyi ;
Zhu, Li ;
Xie, Xinfang ;
Wang, Hui ;
Zhang, Xu ;
Tian, Wenmin ;
Zhang, Yong ;
Dong, Yaping ;
Zan, Jincan ;
Li, Hongyu ;
Zhang, Yuemiao ;
Zhou, Xujie ;
Shi, Sufang ;
Shu, Chutian ;
Liu, Lijun ;
Jin, Jing ;
Lv, Jicheng ;
Zhang, Hong .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 36 (01) :60-72
[47]   Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy [J].
Liu, Youxia ;
Li, Hongfen ;
Yu, Huyan ;
Wang, Fanghao ;
Jia, Junya ;
Yan, Tiekun .
BMC NEPHROLOGY, 2022, 23 (01)
[48]   Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy [J].
Youxia Liu ;
Hongfen Li ;
Huyan Yu ;
Fanghao Wang ;
Junya Jia ;
Tiekun Yan .
BMC Nephrology, 23
[49]   Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy [J].
Yusuke Suzuki ;
Keiichi Matsuzaki ;
Hitoshi Suzuki ;
Keiko Okazaki ;
Hiroyuki Yanagawa ;
Norio Ieiri ;
Mitsuhiro Sato ;
Toshinobu Sato ;
Yoshio Taguma ;
Joe Matsuoka ;
Satoshi Horikoshi ;
Jan Novak ;
Osamu Hotta ;
Yasuhiko Tomino .
Clinical and Experimental Nephrology, 2014, 18 :770-777
[50]   GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1 , the Main Autoantigen in IgA Nephropathy [J].
Jemelkova, Jana ;
Horynova, Milada Stuchlova ;
Kosztyu, Petr ;
Zachova, Katerina ;
Zadrazil, Josef ;
Galuszkova, Dana ;
Takahashi, Kazuo ;
Novak, Jan ;
Raska, Milan .
KIDNEY INTERNATIONAL REPORTS, 2023, 8 (05) :1068-1075